top of page

News & Updates

Filter by:

Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

News & Updates

Jan 10, 2022

Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

Read More
Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA
Lucence Launches First Liquid Biopsy Screening Study in Partnership with the VA Palo Alto Healthcare System

News & Updates

Nov 11, 2021

Lucence Launches First Liquid Biopsy Screening Study in Partnership with the VA Palo Alto Healthcare System

Read More
Lucence Launches First Liquid Biopsy Screening Study in Partnership with the VA Palo Alto Healthcare System
AstraZeneca and Lucence Collaborate in South-East Asia to bring HRD Testing to Ovarian Cancer Patients to guide PARPi Treatment

News & Updates

Nov 10, 2021

AstraZeneca and Lucence Collaborate in South-East Asia to bring HRD Testing to Ovarian Cancer Patients to guide PARPi Treatment

Read More
AstraZeneca and Lucence Collaborate in South-East Asia to bring HRD Testing to Ovarian Cancer Patients to guide PARPi Treatment
Lucence and Yemaachi Launch the AMBER Study to Detect and Characterize Genomic Alterations in Breast Cancer in Women in Africa and Expand Liquid Biopsy Access

News & Updates

Oct 26, 2021

Lucence and Yemaachi Launch the AMBER Study to Detect and Characterize Genomic Alterations in Breast Cancer in Women in Africa and Expand Liquid Biopsy Access

Read More
Lucence and Yemaachi Launch the AMBER Study to Detect and Characterize Genomic Alterations in Breast Cancer in Women in Africa and Expand Liquid Biopsy Access
Lucence Presents Data at ESMO 2021 Showing Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer Patients Undergoing Immunotherapy

News & Updates

Sep 15, 2021

Lucence Presents Data at ESMO 2021 Showing Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer Patients Undergoing Immunotherapy

Read More
Lucence Presents Data at ESMO 2021 Showing Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer Patients Undergoing Immunotherapy
Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

News & Updates

Sep 14, 2021

Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

Read More
Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching
Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

News & Updates

Jun 2, 2021

Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

Read More
Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board
Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

News & Updates

May 11, 2021

Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

Read More
Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer
Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

News & Updates

Mar 24, 2021

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

Read More
Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

1

/

5

bottom of page